Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.6B | 7.9B | 8.5B | 7.7B |
| Cost of revenue | 5.5B | 5.6B | 5.9B | 5.3B |
| Gross profit | 2.2B | 2.3B | 2.6B | 2.4B |
| Operating expense | ||||
| Research & development | 540M | 475M | 527M | 547M |
| Selling general and admin | 1.3B | 1.3B | 1.2B | 1.2B |
| Other operating expenses | — | — | — | — |
| Operating income | 294M | 514M | 799M | 603M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | -1.4B | 180M | 613M | 17M |
| Pretax income | -1.0B | 733M | 1.4B | 608M |
| Tax provision | 5M | 106M | 51M | 96M |
| Net income | -1.1B | 627M | 1.4B | 512M |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 2.3B | 950M | 812M | 1.3B |
| Net income from continuing op. | -1.1B | 627M | 1.4B | 512M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |